Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer.
about
Circulating androgen receptor combined with 18F-fluorocholine PET/CT metabolic activity and outcome to androgen receptor signalling-directed therapies in castration-resistant prostate cancer.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Circulating androgen receptor ...... ion-resistant prostate cancer.
@en
Circulating androgen receptor ...... ion-resistant prostate cancer.
@nl
type
label
Circulating androgen receptor ...... ion-resistant prostate cancer.
@en
Circulating androgen receptor ...... ion-resistant prostate cancer.
@nl
prefLabel
Circulating androgen receptor ...... ion-resistant prostate cancer.
@en
Circulating androgen receptor ...... ion-resistant prostate cancer.
@nl
P2093
P2860
P50
P1433
P1476
Circulating androgen receptor ...... ion-resistant prostate cancer.
@en
P2093
G Paganelli
G Schepisi
S L Burgio
U De Giorgi
P2860
P2888
P356
10.1038/S41598-017-15928-Y
P407
P577
2017-11-14T00:00:00Z